期刊文献+

M蛋白阳性的慢性淋巴细胞白血病患者血清免疫特征分析 被引量:1

Serum immunology analysis of patients with chronic lymphocytic leukemia accompanied with monoclonal M protein
暂未订购
导出
摘要 目的探讨免疫固定电泳在慢性淋巴细胞白血病(CLL)中的临床应用价值。方法对41例检出M蛋白的CLL患者的血清样本进行免疫固定电泳,结合血清总蛋白、球蛋白、免疫球蛋白定量等实验室检查,分析CLL患者的M蛋白特征,研究免疫固定电泳对CLL的诊断意义。结果 41例患者样本经免疫固定电泳分型,发现以IgG型为主,IgG型、IgM型、IgA型分别占53.6%、36.6%、9.8%,其免疫球蛋白定量结果显示IgG型和IgM型对应的免疫球蛋白显著高于健康对照组,但很少引起总球蛋白增加。IgG型CLL患者的IgG水平显著低于IgG型MM患者。结论免疫固定电泳结合免疫球蛋白定量分析有助于CLL的鉴别诊断。 Objective To investigate the clinical value of immune electrophoresis in chronic lymphocytic leukemia (CLL). Methods M protein was detected in 41 serum samples of CLI. patients. Immunofixation electrophoresis,tests of serum total pro lein,globulin,immunoglobulin quantification,and analysis of the M protein were performed in the serum samples. Results After immunofixation electrophoresis, the serum samples contained mainly the IgO type. Types of IgG, IgM, and IgA accounted for 53.6 %, 36.6 %, and 9.8 %, respectively. The immunoglobulin quantitative results showed that types of IgG and IgM both had sig nificantly higher corresponding immunoglobulin than the healthy control group. However, the total globulin rarely increased. IgG levels of CLL patients(IgG type) was significantly lower than the MM patientsfIgG type). Conclusion Immune electrophoresis combined with immunoglobulin quantitative analysis help in the differential diagnosis of CLL.
出处 《国际检验医学杂志》 CAS 2013年第22期2978-2979,共2页 International Journal of Laboratory Medicine
基金 江苏省实验诊断学重点实验室资助项目(XK201114)
关键词 慢性淋巴细胞白血病 M蛋白 免疫固定电泳 免疫球蛋白 chronic lymphoblastic leukemia M protein immunofixation electrophoresis immunoglobulin
  • 相关文献

参考文献9

二级参考文献26

  • 1颜向军,谢海涛.免疫固定电泳技术对多发性骨髓瘤的分型鉴定[J].南华大学学报(医学版),2007,35(1):107-109. 被引量:4
  • 2陈协群,张永清.多发性骨髓瘤的诊断与疗效标准[J].国际输血及血液学杂志,2007,30(4):297-299. 被引量:8
  • 3DECAUDIN D. Mantle cell lymphoma: a biological and therapeutic paradigm[J]. Leuk Lymphoma,2002, 43:773--781.
  • 4VELDERS G A,KLUIN-NELEMANS J C, DE BOER C J, et al. Mantle-cell lymphoma., a population-based clinical study[J]. J Clin Oncol, 1996,14 : 1269 - 1274.
  • 5FERRER A, SALAVERRIA I, BOSCH F, et al. Leukemic involvement is a common feature in mantle cell lymphoma[J]. Cancer,2007,109 :2473--2480.
  • 6COHEN P L,KURTIN P J,DONOVAN K A,et al. Bone marrow and peripheral blood involvement in mantle cell lymphoma[J].Br J Haematol, 1998,101: 302--310.
  • 7MATUTES E, OWUSU-ANKOMAH K, MORILLA R,et al. The immunological profile of B-cell disorders and proposal of a scoringsystem for the diagnosis of CLL[J].Leukemia, 1994,8 : 1640-- 1645.
  • 8MATUTES E,PARRY-JONES N,BRITO-BABAPU LLE V, et al. The leukemic presentation of mantle cell lymphoma:disease features and prognostic factors in 58 patients[J]. Leuk Lymphoma, 2004,45 : 2007 -- 2015.
  • 9VIZCARRA E, MARTINEZ-CLIMENT J A, BENET I,et al. Identification of two subgroups of mantle cell leukemia with distinct elinical and biological features [J]. Hematol J, 2001,2 : 234-- 241.
  • 10Hussein MA,Juturi V,Lieberman I.Multiple mydoma:present and future[J].Curt Opin Oncol,2002,14(1):3l-35.

共引文献36

同被引文献11

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部